- Home
- CDNA vs DGII Comparison
CDNA vs DGII Comparison
Compare CDNA & DGII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- DGII
- Stock Information
- Founded
- CDNA 1998
- DGII 1985
- Country
- CDNA United States
- DGII United States
- Employees
- CDNA N/A
- DGII N/A
- Industry
- CDNA Medical Specialities
- DGII Computer peripheral equipment
- Sector
- CDNA Health Care
- DGII Technology
- Exchange
- CDNA Nasdaq
- DGII Nasdaq
- Market Cap
- CDNA 1.1B
- DGII 1.2B
- IPO Year
- CDNA 2014
- DGII N/A
- Fundamental
- Price
- CDNA $22.94
- DGII $30.39
- Analyst Decision
- CDNA Buy
- DGII Buy
- Analyst Count
- CDNA 8
- DGII 5
- Target Price
- CDNA $26.43
- DGII $34.80
- AVG Volume (30 Days)
- CDNA 823.5K
- DGII 205.8K
- Earning Date
- CDNA 02-26-2025
- DGII 02-05-2025
- Dividend Yield
- CDNA N/A
- DGII N/A
- EPS Growth
- CDNA N/A
- DGII N/A
- EPS
- CDNA N/A
- DGII 0.61
- Revenue
- CDNA $312,775,000.00
- DGII $424,046,000.00
- Revenue This Year
- CDNA $20.27
- DGII $2.01
- Revenue Next Year
- CDNA $11.76
- DGII $5.11
- P/E Ratio
- CDNA N/A
- DGII $49.72
- Revenue Growth
- CDNA 5.26
- DGII N/A
- 52 Week Low
- CDNA $7.42
- DGII $20.17
- 52 Week High
- CDNA $34.84
- DGII $34.82
- Technical
- Relative Strength Index (RSI)
- CDNA 53.43
- DGII 46.77
- Support Level
- CDNA $21.96
- DGII $30.52
- Resistance Level
- CDNA $23.80
- DGII $31.78
- Average True Range (ATR)
- CDNA 1.53
- DGII 0.99
- MACD
- CDNA 0.09
- DGII -0.02
- Stochastic Oscillator
- CDNA 45.88
- DGII 23.66
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
About DGII Digi International Inc.
Digi International Inc is a Minnesota corporation. The company provides business and mission-critical and Internet of Things (IoT) connectivity products and services. It has two segments: IoT Products and Services and IoT Solutions. The IoT Products and Services segment consists of distinct communications products and communication product development services. IoT Solutions segment offers wireless temperature and other environmental condition monitoring services as well as employee task management services. The company generates majority of its revenue from the IoT Products & Services segment. Geographically, the company generates majority of its revenue from its business in the United States and also has its presence in Europe, Middle East and Africa and Rest of the world.